Prospection

Haymarket, United States Founded: 2012 • Age: 14 yrs
AI and cloud-based analytics for healthcare providers are offered.
Annual revenue - Latest available
Total funding $51.7M 2 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Prospection

Prospection is a company based in Haymarket (United States) founded in 2012 by Peter Cronin and Eric Chung. Prospection has raised $51.74 million across 2 funding rounds from investors including CSIRO, Ellerston Capital and Main Sequence. Prospection operates in a competitive market with competitors including Definitive Healthcare, IMS Health, Axtria, Doceree and MDisrupt, among others.

  • Headquarter Haymarket, United States
  • Founders Peter Cronin, Eric Chung
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $51.74 M (USD)

    in 2 rounds

  • Latest Funding Round
    $45 M (USD), Series B

    Sep 13, 2021

  • Investors
    CSIRO

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Prospection

Headcount 50-200
Employee Profiles 20
Employee Profiles
People
Stefan Valko
Software Engineer
People
Eric Chung
Co-founder, Co-ceo
People
Peter Cronin
Founder and Director
People
Jeremy Casorso
Head Of Analytics - ANZ

Unlock access to complete

Funding Insights of Prospection

Prospection has successfully raised a total of $51.74M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $45 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $45.0M
  • First Round

    (12 Feb 2020)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2021 Amount Series B - Prospection Valuation Ellerston Capital
Feb, 2020 Amount Series A - Prospection Valuation Main Sequence , Horizons Ventures

Investors in Prospection

Prospection has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include CSIRO, Ellerston Capital and Main Sequence.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments are made in deep tech founders.
Founded Year Domain Location
Horizons Ventures is focused on investing in deep science and technology.
Founded Year Domain Location
Diversified investment management services are provided by Ellerston Capital.
Founded Year Domain Location

Investments & Acquisitions by Prospection

Investments

Financial Statements - Prospection

Prospection Comparisons

+
Add Comparison
Available on Premium

Competitors of Prospection

Prospection operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Definitive Healthcare, IMS Health, Axtria, Doceree and MDisrupt, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Offers market intelligence and data analytics for healthcare providers and physicians
domain founded_year HQ Location
SaaS and AI-based market intelligence is provided for healthcare companies.
domain founded_year HQ Location
Data analytics and AI solutions are provided for life sciences.
domain founded_year HQ Location
Provider of pharmaceutical advertising and healthcare marketing platform
domain founded_year HQ Location
Software is provided for analyzing and scoring medical diligence.

Latest news on Prospection

Frequently Asked Questions about Prospection

Prospection was founded in 2012 and raised its 1st funding round 8 years after it was founded.

Prospection is headquartered in Haymarket, United States. It is registered at Haymarket, Virginia, United States.

Eric Chung is the current CEO of Prospection. They have also founded this company.

Prospection is a funded company, having raised a total of $51.74M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.74M, raised on Feb 12, 2020.

AI and cloud-based business data analytics software for providers. It analyses large health data sets such as electronic medical records, script claims, registry, and insurance records to provide insights, medication utilization. The products are, PharmDash is a platform that delivers insights into the use, value, and outcomes of different healthcare interventions. PharmMap provides commercial and operational data to a single view using geospatial mapping algorithms.

Prospection's top competitors include Axtria, Doceree and Definitive Healthcare.

Prospection has 4 investors. Key investors include CSIRO, Ellerston Capital, Main Sequence, and Horizons Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available